FDA Grants Approval for Vimseltinib in Treatment of Tenosynovial Giant Cell Tumor (TGCT)
The U.S. Food and Drug Administration (FDA) has officially approved vimseltinib, marketed under the brand name Romvivza™, for the treatment ...
The U.S. Food and Drug Administration (FDA) has officially approved vimseltinib, marketed under the brand name Romvivza™, for the treatment ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine